GlaxoSmithKline may acquire Allergan - MarketLine Financial Deals

GlaxoSmithKline may acquire Allergan

GlaxoSmithKline may acquire Allergan - MarketLine Financial Deals
GlaxoSmithKline may acquire Allergan
Published Mar 25, 2009
2 pages — Published Mar 25, 2009
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

According to Bloomberg, GlaxoSmithKline Plc, a UK-based pharmaceutical and healthcare company, is planning to acquire Allergan, Inc., US-based health care company.

  
Source:
Document ID
MA02681_090326
Country
Country
Ticker
GSK=GB
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "GlaxoSmithKline may acquire Allergan" Mar 25, 2009. Alacra Store. Dec 09, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/GlaxoSmithKline-may-acquire-Allergan-2052-2577>
  
APA:
MarketLine Financial Deals. (2009). GlaxoSmithKline may acquire Allergan Mar 25, 2009. New York, NY: Alacra Store. Retrieved Dec 09, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/GlaxoSmithKline-may-acquire-Allergan-2052-2577>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.